Treatment of Congestive Heart Failure with Angiotensin-Converting Enzyme Inhibitors

Covinsky JO Willett MS . Congestive heart failure. In: DiPiro JT , eds. Pharmacotherapy: A pathophysiologic approach. New York: Elsevier, 1989: 115–49.

McKee PA Castelli WP McNamara PM . The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441–6.

Cleland JGF Dargie HJ . Arrhythmias, catecholamines and electrolytes. Am J Cardiol 1988; 62: 55A–9A.

Packer M . Sudden unexpected death with congestive heart failure: A second frontier. Circulation 1985; 72: 681–5.

Cohn JN Archibald DG Ziesche S . Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986; 314: 1547–52.

The Enalapril CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–35.

Klamerus KJ . Current concepts in clinical therapeutics: Congestive heart failure. Clin Pharm 1986; 5: 481–98.

Francis GS . Plasma catecholamine levels in patients with congestive heart failure. Cardiovasc Rev Rep 1985; 6: 444–54.

Cohn JH . Congestive heart failure in 1987: An overview. Princeton, NJ: Excerpta Medica, 1987: 1–8.

Braunwald E . The history. In: Braunwald E , ed. Heart disease: A textbook of cardiovascular medicine. 3rd ed. Philadelphia: WB Saunders, 1988: 12.

Packer M . Clinical trials in congestive heart failure: Why do studies report conflicting results? Ann Intern Med 1988; 109: 3–5.

Zatuchni J . The treatment of congestive heart failure with diuretic and non-diuretic agents. Clin Ther 1988; 10: 328–49.

Massie B Conway M Yonge R . Skeletal muscle metabolism in patients with congestive heart failure: Relation to clinical severity and blood flow. Circulation 1987; 76: 1009–19.

Soffer RL Sonnenblick EH . Physiologic, biochemical and immunologic aspects of angiotensin-converting enzymes. Prog Cardiovasc Dis 1978; 21: 167–75.

Vidt DG Bravo EL Fouad FM . Captopril. N Engl J Med 1982: 306; 214–9.

Armayor GM Lopez LM . Lisinopril: A new angiotensin-converting enzyme inhibitor. Drug Intell Clin Pharm 1988; 22: 365–72.

DeMarco T Daly PA Liu M . Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: Rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol 1987; 9: 1131–8.

Gomez HJ Cirillo VJ Moncloa F . The clinical pharmacology of lisinopril. J Cardiovasc Dis 1987; 9 (suppl 3): S27–34.

Packer J Lee WH Yushak M . Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986; 315: 847–53.

Burnakis TG Mioduch JH . Combined therapy with captopril and potassium supplementation: A potential for hyperkalemia. Arch Intern Med 1984; 144: 2371–2.

Schuna AA Schmidt GR Pitterle ME . Serum potassium concentrations after initiation of captopril therapy. Clin Pharm 1986; 5: 920–3.

Dzau VJ . Renal effects of angiotensin-converting enzyme inhibition in cardiac failure. Am J Kidney Dis 1987; 10 (suppl 1): 74–80.

Kjekshus J Swedberg K . Tolerability of enalapril in congestive heart failure. Am J Cardiol 1988; 62: 67A–72A.

Packer M Lee WH Medina N Yushak M . Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure. Ann Intern Med 1986; 104: 147–54.

Berkin KE Ball SG . Cough and angiotensin converting enzyme inhibitors. Br Med J 1988; 296: 1279–80.

Dzau VJ Colucci WS Williams GH . Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 1980; 306: 214–9.

The Captopril Multicenter Research Group I. Effect of captopril on progressive ventricular dilatation after myocardial infarction. N Engl J Med 1988; 319: 80–6.

Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 1983; 2: 755–63.

Turini GA Brunner HR Gribic M . Improvement of chronic congestive heart failure by oral captopril. Lancet 1979; 1: 1213–5.

Awan NA Evenson MK Needham KE . Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Am Heart J 1981; 101: 22–31.

McGrath BP Arnolda L Matthews PG . Controlled trial of enalapril in congestive cardiac failure. Br Heart J 1985; 54: 405–14.

Creager MA Massie BM Faxon DP . Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol 1985; 6: 163–70.

Dickstein K . Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure. J Cardiovasc Pharmacol 1987; 9 (suppl 3): S73–81.

Chalmers JP West MJ Cyran J . Placebo-controlled study of lisinopril in congestive heart failure: A multicenter study. J Cardiovasc Pharmacol 1987; 9 (suppl 3): S89–97.

Powers ER Chiaramida A DeMaria AN . A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure. J Cardiovasc Pharmacol 1987; 9 (suppl 3): S82–8.

Jessup M Spielman S Hon T . Lisinopril in the treatment of chronic cardiac failure: A controlled trial. Heart Fail 1987; 3: 114–27.

The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259: 539–44.

Richardson A Scriven AJU Parameshwar J . Can angiotensin converting enzyme inhibitors replace diuretics as sole treatment for mild heart failure? Br Heart J 1987; 57: 80–1.